← Leaderboards
Wei-Xing Zong
Rutgers Biomedical And Health Sciences
$16,617,751
Attributed
$17,385,230
Total exposure
16
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,385,230 · 16
By mechanism
R01$12,150,767 · 5
P30$2,937,541 · 2
T32$1,152,797 · 1
K01$683,802 · 1
R21$382,161 · 1
P41$78,162 · 6
Top collaborators
- Yibin Kang5 shared
- Song Wu2 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsPathway InteractionsMediatingMolecularGrowthTumorRegulationMetabolismIn VivoPlayResponseMetabolicCell DeathPublic Health RelevanceReportingDesignBaseCell GrowthEventProteinsSignal TransductionTumorigenesisLead
Grant awards (61)
Glutamine synthetase in beta-catenin driven hepatocellular carcinoma$492,434
R01 · FY2025 · CA · contact PI
Defective urea cycle promotes oncogenesis of hepatocellular carcinoma$450,997
R01 · FY2025 · CA · contact PI
Cancer Metabolism and Immunology$269,566
P30 · FY2025 · CA · contact PI
Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions$236,431
T32 · FY2025 · CA · contact PI
Glutamine synthetase in beta-catenin driven hepatocellular carcinoma$492,130
R01 · FY2024 · CA · contact PI
Defective urea cycle promotes oncogenesis of hepatocellular carcinoma$450,997
R01 · FY2024 · CA · contact PI
Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions$155,401
T32 · FY2024 · CA · contact PI
Cancer Metabolism and Immunology$8,850
P30 · FY2024 · CA · contact PI
Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions$298,934
T32 · FY2023 · CA · contact PI
Cancer Metabolism and Growth$73,551
P30 · FY2023 · CA · contact PI
Cancer Metabolism and Growth$1,029,093
P30 · FY2022 · CA · contact PI
Glutamine synthetase in cancer cell metabolism and oncogenesis$442,333
R01 · FY2022 · CA · contact PI
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism$347,471
R01 · FY2022 · CA · contact PI
Protein and redox homeostasis in cancer development and therapy$322,382
R01 · FY2022 · CA · contact PI
Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions$314,669
T32 · FY2022 · CA · contact PI
Cancer Metabolism and Growth$1,508,494
P30 · FY2021 · CA · contact PI
Glutamine synthetase in cancer cell metabolism and oncogenesis$451,360
R01 · FY2021 · CA · contact PI
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism$354,563
R01 · FY2021 · CA · contact PI
Protein and redox homeostasis in cancer development and therapy$328,961
R01 · FY2021 · CA · contact PI
Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions$147,362
T32 · FY2021 · CA · contact PI
Cancer Metabolism and Growth$34,771
P30 · FY2021 · CA · contact PI
Glutamine synthetase in cancer cell metabolism and oncogenesis$451,360
R01 · FY2020 · CA · contact PI
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism$354,563
R01 · FY2020 · CA · contact PI
Protein and redox homeostasis in cancer development and therapy$328,961
R01 · FY2020 · CA · contact PI
Glutamine synthetase in cancer cell metabolism and oncogenesis$437,819
R01 · FY2019 · CA · contact PI
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism$343,925
R01 · FY2019 · CA · contact PI
Protein and redox homeostasis in cancer development and therapy$295,387
R01 · FY2019 · CA · contact PI
Cancer Metabolism and Growth$13,216
P30 · FY2019 · CA · contact PI
Glutamine synthetase in cancer cell metabolism and oncogenesis$451,360
R01 · FY2018 · CA · contact PI
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism$354,563
R01 · FY2018 · CA · contact PI
Protein and redox homeostasis in cancer development and therapy$328,961
R01 · FY2018 · CA · contact PI
Cell death regulation in proteotoxic therapy$311,976
R01 · FY2017 · CA · contact PI
Identifying epigenetic targets of c-myc oncogene$168,079
R21 · FY2017 · CA · contact PI
Cell death regulation in proteotoxic therapy$311,976
R01 · FY2016 · CA · contact PI
Identifying epigenetic targets of c-myc oncogene$214,082
R21 · FY2016 · CA · contact PI
Phosphatidylinositol 3-kinases and Autophagy$364,893
R01 · FY2015 · GM · contact PI
Cell death regulation in proteotoxic therapy$231,322
R01 · FY2015 · CA · contact PI
Cell death regulation in proteotoxic therapy$84,737
R01 · FY2015 · CA · contact PI
Phosphatidylinositol 3-kinases and Autophagy$388,651
R01 · FY2014 · GM · contact PI
Cell death regulation in proteotoxic therapy$306,178
R01 · FY2014 · CA · contact PI
Phosphatidylinositol 3-kinases and Autophagy$387,152
R01 · FY2013 · GM · contact PI
Cell death regulation in proteotoxic therapy$314,657
R01 · FY2013 · CA · contact PI
Phosphatidylinositol 3-kinases and Autophagy$367,484
R01 · FY2012 · GM · contact PI
Non-apoptotic cell death pathways in response to metabolic stress and chemotherap$312,836
R01 · FY2012 · CA · contact PI
Phosphatidylinositol 3-kinases and autophagy$13,736
R01 · FY2012 · GM · contact PI
Non-apoptotic cell death pathways in response to metabolic stress and chemotherap$312,826
R01 · FY2011 · CA · contact PI
Non-apoptotic cell death pathways in response to metabolic stress and chemotherap$321,670
R01 · FY2010 · CA · contact PI
Non-apoptotic cell death pathways in response to metabolic stress and chemotherap$320,493
R01 · FY2009 · CA · contact PI
Bcl-2 family proteins in the ER-mediated apoptosis$124,308
K01 · FY2009 · CA · contact PI
Non-apoptotic cell death pathways in response to metabolic stress and chemotherap$319,653
R01 · FY2008 · CA · contact PI
Bcl-2 family proteins in the ER-mediated apoptosis$124,308
K01 · FY2008 · CA · contact PI
Bcl-2 family proteins in the ER-mediated apoptosis$159,462
K01 · FY2007 · CA · contact PI
Bcl-2 family proteins in the ER-mediated apoptosis$137,862
K01 · FY2006 · CA · contact PI
Bcl-2 family proteins in the ER-mediated apoptosis$116,640
K01 · FY2005 · CA
Bcl-2 family proteins in the ER-mediated apoptosis$21,222
K01 · FY2005 · CA
PHYSIO-ARCH: OPEN SOURCE SOFTWARE FOR ARCHIVING OF PHYSIOLOGIC DATA$19,541
P41 · FY2004 · RR
ARCHIVING DATA FROM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS$16,284
P41 · FY2004 · RR
DEVELOPMENT OF CAST RR INTERVAL DATABASE$13,027
P41 · FY2004 · RR
EFFECTIVE OPEN-SOURCE ALGORITHM TO DETECT ONSET OF ARTERIAL BLOOD PRESSURE PULSE$9,770
P41 · FY2004 · RR
ROBUST OPEN-SOURCE ALGORITHM TO DETECT ONSET AND DURATION OF QRS COMPLEXES$9,770
P41 · FY2004 · RR
ARCHIVE OF MOUSE PHYSIOLOGIC DATA FOR NHLBI CARDIOGENOMICS PGA$9,770
P41 · FY2004 · RR